)
Edge15 May 2026
TOMRA: Closing the Loop
The story of TOMRA: from reverse vending machine pioneer to global technology for deposit systems, recycling, and resource optimization.
Sharps Technology
Sharps Technology (STSS) investor relations material
Sharps Technology Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary14 May, 2026
Executive summary
Net loss of $86.2M for Q1 2026, driven by $70.8M unrealized and $10.8M realized losses on Solana (SOL) holdings after adopting a digital commodity treasury strategy in August 2025.
Medical device segment shifted to sales/distribution only; manufacturing and R&D discontinued in October 2025.
Staking revenue from SOL was $3.1M; product revenue from syringes was $192.8K.
Financial highlights
Net revenue: $192.8K from medical device sales; $3.1M staking revenue from SOL.
Gross margin: $(9.8)K; operating expenses totaled $89.4M, including $2.5M related-party consulting fees and $5.1M SG&A.
Net loss: $86.2M vs. net income of $1.9M in Q1 2025.
Cash at quarter-end: $12.3M; working capital: $16.2M.
100,000 SOL sold in Q1 2026 to fund operations.
Outlook and guidance
Future operations to be funded by sale of SOL, equity offerings, and other financing until operating cash flow is sufficient.
Focus remains on medical device distribution and digital asset treasury management.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Sharps Technology
- 2025 saw a $282.5M net loss amid a shift to a SOL treasury strategy and major capital raise.STSS
Q4 202531 Mar 2026 - First revenues, $50M U.S. deal, and expansion into high-margin prefilled syringes drive growth.STSSLife Sciences Virtual Investor Forum29 Dec 2025
- Stockholders considered a reverse split, warrant issuance, and adjournment, with quorum met.STSSStatus Update24 Dec 2025
- Hybrid medical device and SOL treasury strategy, with major warrant-driven capital raise.STSSRegistration Filing23 Dec 2025
- Dual medical device and SOL treasury strategy with $1B shelf, high risk and regulatory exposure.STSSRegistration Filing23 Dec 2025
- Expanding syringe production and global reach, with new supply deals and Nasdaq compliance actions.STSSRegistration Filing16 Dec 2025
- Safety syringe innovator secures major supply deal and maintains Nasdaq listing amid legal risks.STSSRegistration Filing16 Dec 2025
- Patented syringe maker secures $50M+ supply deal; 259,092 shares registered for resale.STSSRegistration Filing16 Dec 2025
- Dual focus on medical devices and a SOL-centric treasury strategy drives high risk and flexibility.STSSRegistration Filing16 Dec 2025
Next Sharps Technology earnings date
Q2 202612 Aug, 2026
Sharps Technology
Next Sharps Technology earnings date
Q2 202612 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage